{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:01:30Z","timestamp":1747206090414,"version":"3.40.5"},"reference-count":53,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["COPD"],"DOI":"10.2147\/copd.s247156","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:26:15Z","timestamp":1586996775000},"page":"787-797","source":"Crossref","is-referenced-by-count":1,"title":["<p>Modelling the Cost-Effectiveness of Indacaterol\/Glycopyrronium versus Salmeterol\/Fluticasone Using a Novel Markov Exacerbation-Based Approach<\/p>"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Bhavesh","family":"Lakhotia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-5744","authenticated-orcid":true,"given":"Florian S","family":"Gutzwiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriy","family":"Danyliv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4501-2083","authenticated-orcid":true,"given":"Ivan","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Thokala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"ref1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2018 Report; 2018. Available from:https:\/\/goldcopd.org\/wp-content\/uploads\/2017\/11\/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. Accessed April 30, 2019."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"020415","DOI":"10.7189\/jogh.05.020415","volume":"5","author":"Adeloye","year":"2015","journal-title":"J Glob Health"},{"key":"ref3","unstructured":"World Health Organization (WHO). The top 10 causes of death. Fact sheet 310; 2017. Updated January 2017. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death. Accessed April 30, 2019. http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/."},{"key":"ref4","unstructured":"US Centers for Disease Control and Prevention. National Vital Statistics Reports. Deaths: final data for 2015; 2015. Available from: https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr66\/nvsr66_06.pdf. Accessed 24 April 2018."},{"key":"ref5","unstructured":"European Respiratory Society (ERS). European lung white book - chapter 2: the economic burden of lung disease; 2016. Updated 2016. Available from: http:\/\/www.erswhitebook.org\/. Accessed 12 October 2016. http:\/\/www.erswhitebook.org\/chapters\/the-economic-burden-of-lung-disease\/."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/thorax.57.10.847","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1465-9921-14-79","volume":"14","author":"Donaldson","year":"2013","journal-title":"Respir Res"},{"key":"ref9","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2016; 2016. Available at: http:\/\/goldcopd.org\/global-strategy-diagnosis-management-prevention-copd-2016\/. Accessed February 5, 2016."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40261-018-0646-0","volume":"38","author":"Capel","year":"2018","journal-title":"Clin Drug Investig"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2147\/COPD.S124420","volume":"12","author":"Wilson","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/CEOR.S116546","volume":"8","author":"Tebboth","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2147\/COPD.S114738","volume":"11","author":"van Boven","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/1753465816657272","volume":"10","author":"Selya-Hammer","year":"2016","journal-title":"Ther Adv Respir Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/CEOR.S105579","volume":"8","author":"Eklund","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2147\/COPD.S159103","volume":"13","author":"Chan","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.11622\/smedj.2018022","volume":"59","author":"Tee","year":"2018","journal-title":"Singapore Med J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12931-017-0688-5","volume":"18","author":"Bjermer","year":"2017","journal-title":"Respir Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40258-016-0256-z","volume":"14","author":"Reza Maleki-Yazdi","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40273-012-0016-3","volume":"31","author":"Asukai","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jval.2018.10.008","volume":"22","author":"Hoogendoorn","year":"2019","journal-title":"Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"A500","DOI":"10.1016\/j.jval.2015.09.1414","volume":"18","author":"Geitona","year":"2015","journal-title":"Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.rmed.2014.09.015","volume":"108","author":"Price","year":"2014","journal-title":"Respir Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1465-9921-14-116","volume":"14","author":"Beeh","year":"2013","journal-title":"Respir Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/COPD.S94259","volume":"10","author":"Kerkhof","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1038\/npjpcrm.2016.46","volume":"26","author":"Marg\u00fcello","year":"2016","journal-title":"NPJ Primary Care Respiratory Medicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3109\/15412555.2015.1007931","volume":"12","author":"Molinari","year":"2015","journal-title":"Copd"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e006171","DOI":"10.1136\/bmjopen-2014-006171","volume":"4","author":"Mullerova","year":"2014","journal-title":"BMJ Open"},{"key":"ref31","first-page":"98","volume":"7","author":"Blanchette","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2147\/COPD.S118523","volume":"11","author":"Chen","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/COPD.S54417","volume":"9","author":"Punekar","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2147\/COPD.S90148","volume":"10","author":"Dhamane","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2147\/COPD.S132825","volume":"12","author":"Souliotis","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1164\/ajrccm.161.2.9901044","volume":"161","author":"Scanlon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"ref37","unstructured":"Statistics Sweden. Life expectancy in Sweden 2011\u20132015. Available from: https:\/\/www.scb.se\/Statistik\/_Publikationer\/BE0701_2016A01R_BR_BE51BR1604.pdf. Accessed April 25 2018).."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2466-12-1","volume":"12","author":"Lindberg","year":"2012","journal-title":"BMC Pulm Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1378\/chest.130.4.1117","volume":"130","author":"Rutten-van Molken","year":"2006","journal-title":"Chest"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S149633","volume":"13","author":"Lisspers","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref41","unstructured":"Swedish Agency for Health Technology Assessment and Assessment of Social Services; 2016. Available from: http:\/\/www.sbu.se\/en\/. Accessed December 2016."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/thx.2010.152876","volume":"66","author":"Garcia-Aymerich","year":"2011","journal-title":"Thorax"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40273-017-0553-x","volume":"35","author":"Bermejo","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1524-4733.2008.00489.x","volume":"12","author":"Drummond","year":"2009","journal-title":"Value in Health"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/CEOR.S14404","volume":"3","author":"Goeree","year":"2011","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"S431","DOI":"10.21037\/jtd.2016.07.10","volume":"8","author":"Price","year":"2016","journal-title":"J Thoracic Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40273-016-0448-2","volume":"35","author":"van der Schans","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"ref50","unstructured":"The R Foundation. The R project for statistical computing. Available from: https:\/\/www.r-project.org\/. Accessed April 30, 2019. 2019."},{"key":"ref51","unstructured":"RStudio I. Shiny. From R Studio; 2019. Available from: https:\/\/shiny.rstudio.com\/. Accessed April 30 2019."},{"key":"ref52","unstructured":"Novartis. Data on file. 2015."},{"key":"ref53","unstructured":"TLV (Dental and Pharmaceutical Benefits Agency S. 2016. Available from: http:\/\/www.tlv.se\/beslut\/sok\/lakemedel\/. Accessed June 22 2016."}],"container-title":["International Journal of Chronic Obstructive Pulmonary Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=57436","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=57436","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:26:28Z","timestamp":1586996788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/modelling-the-cost-effectiveness-of-indacaterolglycopyrronium-versus-s-peer-reviewed-article-COPD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":53,"URL":"https:\/\/doi.org\/10.2147\/copd.s247156","relation":{},"ISSN":["1178-2005"],"issn-type":[{"type":"electronic","value":"1178-2005"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}